https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/dcis-endocrine-therapy-duration-tied-benefit-young-patients-reject-et/
0
0
11/11/22 at 3:55pm
Organization
Cancertherapyadvisor.com
Author
Erin Clancy
Two new studies shed light on the complexity of preventing subsequent breast cancer events in patients with ductal carcinoma in situ.
Create an account
or login to join the discussion